No products
Product successfully added to your shopping cart
There are 0 items in your cart. There is 1 item in your cart.
Categories
- Products Overview
- All Products
- Neuropsychochemicals
- SEP-OX Optimized Xtracts
- TLR-OA Optimized Agents
- Neurogenic/Neuroprotection Research
- Addiction Research
- Nootropic Research
- Antidepressant Research
- Anxiolytic/Stress Research
- Analgesia Research
- Vigilance/Focus Research
- Libidogenic Research
- Anti-inflammatory Research
- Cannabinergics
- Glutamatergics
- Opioidergics
- ADD/ADHD Research
- Nicotinergics
- Sleep Promotion Research
- Anti-Obesity Research
- Serotonergics
- Dopaminergics
- Anti-Aging/Longevity Research
- Anti-Cancer Research
- Myotrophic/Anabolic Research
- Anti-Estrogen/Prolactin Research
- Extracts
- Peptides & Antigens
- HairLoss Research
- GABAergics
- Prostaglandin Research
- Revolutionary Research
- Thyroid Research
- Cosmetic Enhancement Research
Research related to GABA system including agents of the benzodiazepine, barbituate, and alcohol classes, among other classes so related.
GABAergics There are 3 products.
-
Fasoracetam 99% CAS 110958-19-5
Fasoracetam (a.k.a. NS-105 and LAM-105) is a potent HACU-inhibiting, cAMP-modulating, GABAB receptor upregulating/antagonizing, mGluR-modulating, non-monoaminergic anti-depressant nootropic. Research Indications: Nootropic, Antidepressant, Anxiolytic, ADHD Research, Addiction Cessation, GABAergics/Benzodiazepine Research
$ 19.90In stock -
Baclofen 99% CAS 1134-47-0
Baclofen as a full agonist at the GABA-B receptor acts as a centrally-acting anxiolytic and skeletal muscle relaxant. As well, it shows efficacy in treatment of alcohol cessation. Research Indications: GABAergic Research, Anxiolytic Research, Addiction Cessation Research
$ 99.95In stock -
Flumazenil 99% CAS 78755-81-4
Flumazenil is a potent benzodiazepine receptor antagonist. Flumazenil administration has been demonstrated to have efficacy to reverse benzodiazepine tolerance and create a facilitation of rapidly alleviating PAWS (Post-Acute Withdrawal Syndrome). Research Indications: Addiction Research, GABAergic/Benzodiazepine Research, Anxiolytic Research
$ 69.95In stock
